FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and concerns prevention of postpericardiotomy syndrome and atrial fibrillation paroxysms in cardiosurgical patients. That is ensured by administering colchicine 500 mg 2–4 hours before the onset of the surgical intervention and 500 mg twice day for 10 days after the operation.
EFFECT: method provides effective prevention of postpericardiotomy syndrome and atrial fibrillation paroxysms with no side effects ensured by the drug administration regimen developed taking into account its pharmacodynamic characteristics.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF POSTPERICARDIOTOMY SYNDROME IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER CORONARY BYPASS SURGERY | 2014 |
|
RU2556198C1 |
| METHOD FOR PREVENTION OF CARDIAC RHYTHM DISTURBANCE IN CORONARY BYPASS | 2009 |
|
RU2392939C1 |
| METHOD FOR INTENSIVE CARE OF MULTIPLE-ORGAN-FAILURE SYNDROME | 2010 |
|
RU2444379C2 |
| METHOD FOR PREDICTION OF POST-SERDIOTHYTHOMIC SYNDROME IN PATIENTS WITH ISCHEMIC HEART DISEASE (IHD) AFTER AORTOCORONARY SHUNTING | 2016 |
|
RU2619218C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING POLYORGAN INSUFFICIENCY IN CARDIO-SURGICAL PATIENTS | 2010 |
|
RU2422092C1 |
| METHOD FOR PREVENTION OF RECURRENT ATRIAL FIBRILLATION FOLLOWING CARDIOSURGICAL OPERATIONS | 2014 |
|
RU2567920C1 |
| METHOD FOR INTRAOPERATIVE STABILIZATION OF PATIENT'S HOMEOSTASIS IN CARDIOSURGICAL INTERVENTION IN CONDITIONS OF PROLONGED ARTIFICIAL BLOOD CIRCULATION | 2019 |
|
RU2723752C1 |
| METHOD FOR PREVENTION OF DEVELOPMENT OF SYSTEMIC INFLAMMATORY RESPONSE IN CARDIAC-SURGICAL PATIENTS AFTER ARTIFICIAL CIRCULATION | 2016 |
|
RU2641173C1 |
| METHOD FOR PREDICTION OF RISK OF MULTIPLE ORGAN FAILURE SYNDROME DEVELOPMENT IN PATIENTS AFTER HEART BYPASS | 2017 |
|
RU2641033C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING EARLY ABDOMINAL COMPLICATIONS IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY IN CARDIOPULMONARY BYPASS | 2018 |
|
RU2692455C1 |
